<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04515901</url>
  </required_header>
  <id_info>
    <org_study_id>7978</org_study_id>
    <nct_id>NCT04515901</nct_id>
  </id_info>
  <brief_title>Spenopalatine Ganglion Block for Treatment of Post-dural Puncture Headaches</brief_title>
  <acronym>SPGB</acronym>
  <official_title>Early Intervention Sphenopalatine Ganglion Blocks (SPGBs) Versus Standard Conservative Management of Post Dural Puncture Headache in Obstetric Patients - A Randomized Feasibility Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>McMaster University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postdural puncture headache (PDPH) is a severe, debilitating complication of dural puncture&#xD;
      that can arise from insertion of an epidural or spinal needle for labour analgesia.&#xD;
      Presently, the conservative treatment options for PDPH have limited effectiveness and the&#xD;
      gold standard treatment for PDPH, an epidural blood patch, is an invasive intervention with&#xD;
      the potential for serious complications. There is a growing number of case reports and&#xD;
      retrospective studies that suggest a sphenopalatine ganglion block (SPGB) with local&#xD;
      anesthetic may offer an effective, safe, and easy-to-administer treatment option for PDPH in&#xD;
      postpartum patients. We aim to conduct a feasibility study to assess whether a randomized&#xD;
      controlled trial is feasible comparing whether early intervention SPGB with the option for&#xD;
      repeat, patient self-administered SPGBs versus current standard conservative management can&#xD;
      reduce the severity and duration of PDPH pain and improve patient functional status.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2, 2022</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Enrollment rate</measure>
    <time_frame>6 months</time_frame>
    <description>Number of consented patients over number of number of eligible patients</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">22</enrollment>
  <condition>Postdural Puncture Headache</condition>
  <arm_group>
    <arm_group_label>SPGB</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Via a soft tip 20-gauge long IV catheter attached to a 3 mL syringe will be filled with 2 mL of 2% viscous lidocaine. The 2% viscous lidocaine will be administered according to the method of Barre.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>It will be adminstered the same as the experimental arm but with methylcellulose and cherry flavouring to match odour and taste.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2% lidocaine</intervention_name>
    <description>Viscous lidocaine</description>
    <arm_group_label>SPGB</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Methylcellulose and cherry flavouring</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18-45&#xD;
&#xD;
          -  Confirmed PDPH as per ICHD-3 diagnostic criteria&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  American Society of Anesthesiologists (ASA) class 4 and above&#xD;
&#xD;
          -  History of chronic headaches or migraines requiring prescription medication&#xD;
&#xD;
          -  Known nasal septal deformity or abnormality&#xD;
&#xD;
          -  Known allergy to amide anesthetics&#xD;
&#xD;
          -  Intrathecal catheters&#xD;
&#xD;
          -  Patients who received EBP on the initial presentation with PDPH who declined a trial&#xD;
             of conservative management&#xD;
&#xD;
          -  Postpartum complication delaying maternal discharge&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Angle P, Tang SL, Thompson D, Szalai JP. Expectant management of postdural puncture headache increases hospital length of stay and emergency room visits. Can J Anaesth. 2005 Apr;52(4):397-402.</citation>
    <PMID>15814755</PMID>
  </reference>
  <reference>
    <citation>Barr√© F. Cocaine as an abortive agent in cluster headache. Headache. 1982 Mar;22(2):69-73.</citation>
    <PMID>7085264</PMID>
  </reference>
  <reference>
    <citation>Channabasappa SM, Manjunath S, Bommalingappa B, Ramachandra S, Banuprakash S. Transnasal sphenopalatine ganglion block for the treatment of postdural puncture headache following spinal anesthesia. Saudi J Anaesth. 2017 Jul-Sep;11(3):362-363. doi: 10.4103/sja.SJA_59_17.</citation>
    <PMID>28757848</PMID>
  </reference>
  <reference>
    <citation>Choi PT, Galinski SE, Takeuchi L, Lucas S, Tamayo C, Jadad AR. PDPH is a common complication of neuraxial blockade in parturients: a meta-analysis of obstetrical studies. Can J Anaesth. 2003 May;50(5):460-9.</citation>
    <PMID>12734154</PMID>
  </reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 11, 2020</study_first_submitted>
  <study_first_submitted_qc>August 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 17, 2020</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

